NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
NINDS provides funding for Small Business Concerns to conduct clinical trials on neurological products in line with their mission and goals.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health (NIH)
Due Dates: November 17, 2025
Funding Amounts: No specific ceiling or floor; budget must be reasonable for project scope. Only STTR Phase II and Fast-Track applications are allowed.
Summary: Supports small businesses in conducting investigator-initiated exploratory clinical trials for neurological products relevant to NINDS.
Key Information: Only STTR Phase II and Fast-Track applications are accepted; Phase I only as part of Fast-Track.
Description
This program provides funding for U.S. small businesses to conduct investigator-initiated exploratory clinical trials focused on products aligned with the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS). Supported projects may evaluate drugs, biologics, devices, diagnostics, as well as surgical, behavioral, or rehabilitation therapies. The grant is specifically for Small Business Technology Transfer (STTR) Phase II and Fast-Track applications; standalone Phase I applications are not accepted (Phase I is only allowed as part of a Fast-Track submission).
